Diagnosis and management of Ebola samples in the laboratory

References

• McMichael AJ. Environmental and social influences on emerging infectious diseases: past, present and future. Philos Trans R Soc B Biol Sci. 2004;359(1447):1049–1058.
   PubMed Web of Science ®Google Scholar
• Kuhn J, Andersen K, Baize S, et al. Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses [Internet]. 2014;6(11):4760–4799. Available from: http://www.mdpi.com/1999-4915/6/11/4760/
   PubMed Web of Science ®Google Scholar
• Cenciarelli O, Pietropaoli S, Malizia A, et al. Ebola virus disease 2013-2014 outbreak in west Africa: an analysis of the epidemic spread and response. Int J Microbiol. 2015;2015:1–12.
   Google Scholar
• Mackenzie JS, Drury P, Arthur RR, et al. The global outbreak alert and response network. Glob Public Health. 2014;9(9):1023–1039.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker. Geneva (Switzerland): World Health Organization; 2014.
   Google Scholar
• World Health Organization. How to safely collect blood samples by phlebotomy from patients suspected to be infected with Ebola. Guideline. 2014. 7 p.
   Google Scholar
• Bai X, Fischer S, Keshavjee S, et al. Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion. Transpl Int. 2000;13(2):146–150.
   PubMed Web of Science ®Google Scholar
• Beutler E, Gelbart T, Kuhl W. Interference of heparin with the polymerase chain reaction. Biotechniques. 1990;9(2):166.
   PubMed Web of Science ®Google Scholar
• World Health Organization. How to safely ship human blood samples from suspected Ebola cases within a country by road, rail and sea. Guideline. 2014. 5 p.
   Google Scholar
• United States Government Publishing Office. Hazardous materials regulations. Electron Code Fed Regul [Internet]. 2016. Available from: http://www.ecfr.gov/cgi-bin/text-idx?SID=6094f4c86cef1403550ec3f80babfb85&tpl=/ecfrbrowse/Title49/49CIsubchapC.tpl
   Google Scholar
• Sterk E. Filovirus haemorrhagic fever guideline - Médecins Sans Frontières. Guideline. 2008. 138 p.
   Google Scholar
• United Nations Economic Commission for Europe. European agreement concerning the international carriage of dangerous goods. Geneva (Switzerland): United Nations; 2015. p. 197–203.
   Google Scholar
• International Air Transport Association. Dangerous goods regulations manual. IATA. 2016;1(57):1062 p.
   Google Scholar
• World Health Organization. Personal protective equipment in the context of filovirus disease outbreak response. Rapid Advice Guideline. 2014 Oct;1–12.
   Google Scholar
• Plebani M. The detection and prevention of errors in laboratory medicine. Ann Clin Biochem. 2010;47(Pt 2):101–110.
   PubMed Web of Science ®Google Scholar
• Grolla A, Mehedi M, Lindsay R, et al. Enhanced detection of Rift Valley fever virus using molecular assays on whole blood samples. J Clin Virol. 2012;54(4):313–317.
   PubMed Web of Science ®Google Scholar
• Janvier F, Foissaud V, Delaune D, et al. Deployment of the French Military Field Laboratory dedicated to Ebola virus infected patients in Guinea, January 2015 to July 2015. J Infect Dis. 2015. doi:10.1093/infdis/jiv554. [Epub ahead of print]
   Web of Science ®Google Scholar
• Farrell J, Rose A. Temperature effects on microorganisms. Annu Rev Microbiol. 1967;21:101–120.
   PubMed Web of Science ®Google Scholar
• Balows A, Hausler W, Lennette E, et al. Laboratory diagnosis of infectious diseases: principles and practices. Volume II: viral, rickettsial, and chlamydial diseases. New York (NY): Springer-Verlag; 1988.
   Google Scholar
• Mitchell SW, McCormick JB. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol. 1984;20(3):486–489.
   PubMed Web of Science ®Google Scholar
• Elliott LH, McCormick JB, Johnson KM. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol. 1982;16(4):704–708.
   PubMed Web of Science ®Google Scholar
• Dedkov VG, Magassouba NF, Safonova MV, et al. Development and evaluation of a real-time RT-PCR assay for the detection of Ebola virus (Zaire) during an Ebola outbreak in Guinea in 2014–2015. J Virol Methods. 2015;228:26–30.
   PubMed Web of Science ®Google Scholar
• Grolla A, Jones S, Kobinger GP, et al. Flexibility of mobile laboratory unit in support of patient management during the 2007 Ebola-Zaire outbreak in the Democratic Republic of Congo. Zoonoses Public Health. 2012;59:151–157.
   PubMed Web of Science ®Google Scholar
• Lu H, Qian J, Kargbo D, et al. Ebola virus outbreak investigation, Sierra Leone, September 28–November 11, 2014. Emerg Infect Dis. 2015;21:1921–1927.
   PubMed Web of Science ®Google Scholar
• Weller SA, Bailey D, Matthews S, et al. Evaluation of the Biofire FilmArray Biothreat E-test (v2.5) for rapid identification of Ebola virus disease in heat-treated blood samples obtained in Sierra Leone and United Kingdom. J Clin Microbiol. 2016 Jan;54(1):114–119. doi:10.1128/JCM.02287-15.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156–159.
   PubMed Web of Science ®Google Scholar
• Cox RA. The use of guanidinium chloride in the isolation of nucleic acids. Methods Enzymol. 1968;12:120–129.
   Google Scholar
• Nozaki Y, Tanford C. The solubility of amino acids, diglycine, and triglycine in aqueous guanidine hydrochloride solutions. J Biol Chem. 1648–1652;245(7):1970.
   Google Scholar
• Gordon JA. Denaturation of globular proteins. Interaction of guanidinium salts with three proteins. Biochemistry. 1972;11(10):1862–1870.
   PubMed Web of Science ®Google Scholar
• de La Vega M-A, Stein D, Kobinger GP, et al. Ebolavirus evolution: past and present. PLOS Pathog. 2015;11(11):e1005221.
   PubMed Web of Science ®Google Scholar
• Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179:S76–S86.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ebola heamorrhagic fever in Zaire. Geneva (Switzerland): World Health Organization; 1978. Vol. 56; p. 271–293.
   Google Scholar
• Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78(8):4330–4341.
   PubMed Web of Science ®Google Scholar
• Okware SI, Omaswa FG, Zaramba S, et al. An outbreak of Ebola in Uganda. Trop Med Int Heal. 2002;7(12):1068–1075.
   PubMed Web of Science ®Google Scholar
• Sanchez A, Ksiazek TG, Rollin PE, et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis. 1999;179(Suppl 1):S164–S169.
   PubMed Web of Science ®Google Scholar
• Towner JS, Sealy TK, Ksiazek TG, et al. High throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis. 2007;196(s2):S205–S212.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Niu J, Zhang Y, et al. Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol. 2006;44(10):3557–3561.
   PubMed Web of Science ®Google Scholar
• de La Vega M-A, Caleo G, Audet J, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J Clin Invest. 2015;125(12):4421–4428.
   PubMed Web of Science ®Google Scholar
• Cepheid. Instructions for use: Xpert ® Ebola Assay. Solna (Sweden): Cepheid; 2015.
   Google Scholar
• Pinsky BA, Sahoo MK, Sandlund J, et al. Analytical performance characteristics of the Cepheid GeneXpert Ebola Assay for the detection of Ebola virus. PLoS One. 2015;10(11):e0142216.
   PubMed Web of Science ®Google Scholar
• Esakova O, Krasilnikov AS. Of proteins and RNA : the RNase P/MRP family. RNA. 2010;16:1725–1747.
   PubMed Web of Science ®Google Scholar
• Lu G, Zhang J, Zhang C, et al. One-step reverse-transcription FRET-PCR for differential detection of five Ebolavirus species. PLoS One. 2015;10(5):e0126281.
   Web of Science ®Google Scholar
• Das S, Rundell MS, Mirza AH, et al. A Multiplex PCR/LDR Assay for the simultaneous identification of category a infectious pathogens: agents of viral hemorrhagic fever and variola virus. PLoS One. 2015;10(9):e0138484.
   Web of Science ®Google Scholar
• Van Den Bergh R, Chaillet P, Sow MS, et al. Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea. Emerg Infect Dis. 2016;22(2):210–216.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Selection and use of Ebola in vitro diagnostic (IVD) assays. Geneva (Switzerland): World Health Organization; 2015.
   Google Scholar
• World Health Organization. Product report: ReEBOV^TM Antigen Rapid Test kit. Geneva (Switzerland): World Health Organization; 2014.
   Google Scholar
• World Health Organization. Interim guidance on the use of rapid Ebola antigen detection tests. Geneva (Switzerland): World Health Organization; 2015 Mar. p. 1–2.
   Google Scholar
• Broadhurst MJ, Kelly JD, Miller A, et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;6736(15):1–8.
   Google Scholar
• Cook BWM, Cutts TA, Nikiforuk AM, et al. Evaluating environmental persistence and disinfection of the Ebola virus Makona variant. Viruses. 1975–1986;7(4):2015.
   Google Scholar
• Abaxis. Piccolo Xpress chemistry analyzer operator’s manual. Union City (CA): Abaxis Inc.; 2007.
   Google Scholar
• Owen WE, Caron JE, Genzen JR. Liver function testing on the Abaxis Piccolo Xpress: use in Ebola virus disease protocols. Clin Chim Acta. 2015;446:119–127.
   PubMed Web of Science ®Google Scholar
• Abbott. i-STAT ® 1 system manual. Princeton (NJ): Abbot Point of Care Inc.; 2013 Mar. 664 p.
   Google Scholar
• Médecins Sans Frontières. Pushed to the limit and beyond: A year into the largest ever Ebola outbreak. Brussels (Belgium): Médecins Sans Frontièeres; 2015.
   Google Scholar
• Bhagat CI, Lewer M, Prins A, et al. Effects of heating plasma at 56 degrees C for 30 min and at 60 degrees C for 60 min on routine biochemistry analytes. Ann Clin Biochem. 2000;37(Pt 6):802–804.
   PubMed Web of Science ®Google Scholar
• Feldmann H, Geisbert T. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849–862.
   PubMed Web of Science ®Google Scholar
• Ansari A. Clinical features and pathobiology of Ebolavirus infection. J Autoimmun. 2014;55:1–9.
   PubMed Web of Science ®Google Scholar
• Tempestilli M, Pucci L, Notari S, et al. Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients. Clin Chem Lab Med. 2015;53(12):1967–1973.
   PubMed Web of Science ®Google Scholar
• LeBlanc JJ, Heinstein C, MacDonald J, et al. Pushing the limits of chemistry point-of-care testing for the management of patients under investigation for Ebola virus disease. Ann Clin Biochem. 2015;0(0):1–4.
   Google Scholar
• Carroll MW, Matthews DA, Hiscox JA, et al. Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa. Nature. 2015;524(7563):97–101.
   PubMed Web of Science ®Google Scholar
• Hoenen T, Groseth A, Rosenke K, et al. Nanopore sequencing as a rapidly deployable Ebola outbreak tool. Emerg Infect Dis. 2016;22(2):331–334.
   Web of Science ®Google Scholar